Archive 2003

• Exhibition
• Press release
• General information

News		Date
Eurogentec: Results improving and international expansion Today, Eurogentec publishes its annual results for the 2002-2003 financial year, which closed on 31 March 2003 read more >>		June 2003
Epoch Biosciences Sells Specialty Oligonucleotide Business to Eurogentec Epoch Biosciences, Inc. (Nasdaq: EBIO), a provider of proprietary products that accelerate genomic analysis, and Eurogentec S.A., a Belgium-based supplier of products and services for European life science companies, announced a definitive agreement for Epoch to sell the assets and customer base of its specialty oligonucleotide operations located in San Diego, California to Eurogentec. read more >>		May 2003
Exiqon and EUROGENTEC announce market licence agreement on the use of Locked Nucleic Acid (LNA) A long-term license agreement including co-development projects on LNA-based genomics products will allow Eurogentec to market products and custom oligos enhanced by locked nucleic acids. read more >>		March 2003